Latest News

Centanafadine's FDA priority review signals potential innovation in ADHD treatment, offering a new nonstimulant option for diverse patient needs.

Colorectal cancer emerges as the top cancer killer for US adults under 50, highlighting urgent needs for early detection and screening strategies.

The FDA updates Afrezza's prescribing information, enhancing dosing guidance for adults switching from injected insulin to improve glycemic control.

ACON Laboratories launches the first FDA-cleared at-home test for RSV, influenza, and COVID-19, enhancing respiratory symptom management for families.

Clevenger explains how better recognition of agitation in Alzheimer disease, and stronger caregiver–clinician communication, can meaningfully improve outcomes.

National health trends for 2025 show a complex mix of improved cancer screenings alongside rising chronic conditions and affordability gaps.

Results show significant concerns about topical steroid use in chronic skin diseases, highlighting the need for proactive long-term management strategies.

Multiple lab options can lead to incorrect UACR testing. Clear ordering practices are essential for actionable results.